Thyrocare Technologies Limited (THYROCARE) reports Q1FY27 results with a 24% YoY revenue growth and a 34% YoY PAT increase.
Thyrocare Technologies Limited (NSE: THYROCARE) stock moves up 5% intraday to ₹550.3, showing a bounce despite a breakdown trendline status.
Thyrocare Technologies Limited (NSE: THYROCARE) stock gains 5% intraday, trading at ₹537.5 despite a breakdown trendline status.
Thyrocare Technologies Limited (NSE: THYROCARE) stock moves down 5% intraday at ₹527.15, retracing after clearing resistance in the Healthcare > Diagnostics.
Thyrocare Technologies reports strong Q4FY26 results with 20% YoY revenue growth, 31% EBITDA growth, and 128% PAT growth.
